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Introduction
The use of changes in light-scattering properties as a
means ofmonitoring the reaction between two species has
been used for many years. In recent years interest has
tended to concentrate on monitoring the turbidity of a
reaction mixture. The reaction between polyvalent
antigens and the appropriate antibodies may be moni-
tored by the development of the turbidity as a result of
immunoaggregate formation; this technique is used
routinely for the quantitation of specific proteins. Reac-
tions are monitored at 340 nm for short periods of time,
generally less than 10 min and, as a consequence, results
can be produced quickly.
The advent of the discretionary analyser capable of
performing many different types of analyses has in
general terms favoured the employment of methods with
short reaction times to improve the throughput of
analyses. The short reaction times demonstrated by
immunoturbidimetric techniques favours their use on this
type of analyser.
The formation of a light-scattering immunoaggregate
requires that the antigen is polyvalent. This technique
can, however, be employed for the measurement of a
small monovalent antigen; the analyte (hapten) in the
sample inhibits the formation of an immunoaggregate
formed from the antibody and a polyvalent antigen
synthesized from the hapten linked to a large molecule or
light-scattering particle.
An assay has been developed for the measurement of
thyroxine whereby thyroxine in the patient’s sample
inhibits the formation of an immunaggregate from
antibody bound to latex particles and thyroxine
conjugated to Ficoll. Trypsin is included in the reaction
mixture to minimize interference from serum proteins.
We report our experience of this assay using an RA1000
discretionary analyser (Technicon Instruments,
Basingstoke, UK).
Materials and methods
The Technicon Total Thyroxine reagents were prepared
exactly according to the manufacturer’s instructions. The
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system comprises a buffered reagent containing a
thyroxine-Ficoll conjugate and trypsin and a reagent
containing monoclonal antibodies to thyroxine bound to
latex particles.
Briefly, the method involves the addition of sample (26
1) to the thyroxine-Ficoll conjugate reagent (190 tl).
After an incubation of 4 min, 190 1 of the thyroxine
antibody reagent is added. After a delay of min the
increase in turbidity is measured at 600 nm for a period of
135 s.
A set of six calibrators with assigned thyroxine values can
be purchased from Technicon Instruments.
Experimental procedures and results
Precision
Three commercial lyophilized serum preparations were
employed in this study (Lyphocheck I, II and III,
Biorad, Watford, UK). Fresh bottles of each material
were reconstituted at the beginning of each week; the
reconstituted material was stored at 4 C.
Twenty aliquots ofeach material were run in one batch to
establish the within-run precision. The data are shown in
table 1.
Table 1. Imprecision (N 20) o flight-scattering thyroxine assay.
Mean
thyroxine CV
nmol/1 SD %
Within-batch
Between-day
Daily calibration
Weekly calibration
23"1 1"95 8"4
103"9 2" 12 2"0
201’6 3"35 1"7
25"2 2"19 8"7
99"5 5"15 5"2
197"2 11’07 5"6
28"2 5’20 18’5
99"9 6’77 5’8
206"2 7"43 3"6
A calibration curve was established on each day for a
period of 20 working days. Each of the reconstituted
materials was analysed, once on each working day. The
thyroxine level on each day was determined using the
calibration curve established on the first day of the week
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and that established on each working day. The data are
shown in table 1.
A typical calibration curve is shown in figure 1.
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Figure 1. A pical calibration curve for the lht-scattering
immunoassay ofthyroxine.
Linearity
A sample with a high thyroxine level was diluted with
zero calibrator in varying proportions and duplicate
determinations of the thyroxine level made. Regression
analysis ofthe data gave a correlation coefficient of0"9987
when the observed value was compared with the expected
value.
Detection limit
The zero calibrator was analysed 10 times in one batch
and the absorbance change used to determine the mean
absorbance change (0"0796 min) and the standard
deviation (0"008). The detection limit defined as the
signal change equal to three times the standard deviation
of the base-line was calculated ti’om the initial calibration
curve as 4"1 nmol/1 (in the sample).
Method comparison
The thyroxine level was determined using the turbidi-
metric method on 106 patients samples; the thyroxine
level was also determined using an in-house radio-
immunoassay. The data are shown in figure 2. The
radioimmunoassay was calibrated with material
obtained from Ciba Corning (MAGIC calibrator set,
Ciba Corning, Halstead, UK).
Recovery ofpure analyte
Thyroxine (obtained from Sigma Chemical Company,
Poole, Dorset, UK) was dissolved in ethanol. A one in 500
dilution of this stock was made in a 100 mmol/l phosphate
buffer, pH 7"4, containing 10 g/1 bovine serum albumin.
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Figure 2. Comparison ofthyroxine results obtained with the light-
scattering(y) and radio-immunoassay(x) methods. Regression
analysis using the method of Deming [3] gave a correlation
coefficient(r) of0"971 with a liney 0"976x + 7.37, n 100.
This substock had a calculated thyroxine level of 2250
nmol/1. The substock was then diluted one in 41, one in 21
and one in 11 with the zero calibrator and the thyroxine
level assayed in duplicate. The mean recov..ery at a level of
55 and 107 nmol/1 was 100"3% (range 96"2-103"4%). At a
level of 205 mmol/1 the recovery was 117% (range
116.4-118.3/o).
Analysis of the Technicon calibrators by radioimmuno-
assay indicated a level of318 nmol/1 at an assigned value
of308 nmol/1 with agreement at the lower levels (less than
3% difference) whilst analysis of the Ciba Corning
calibrators in the light-scattering method indicated an
underestimation of 13 nmol/1 at a level of 193 nmol/1, with
agreement at the lower levels.
Endogenous interferents
Haemolysis, icterus, lipaemia: a serum sample was spiked
with an haemolysate and bilirubin solution to varying
levels. The thyroxine level )f each mixture was then
assayed in duplicate. The results indicate the mean effect
on the apparent thyroxine level was a decrease of 10
nmol/1 in the presence ofhaemoglobin at a concentration
of 0"5 g/dl. There was a gradual increase in the apparent
thyroxine level equivalent to 21 nmol/1 at a bilirubin level
of 500 umol/1. The thyroxine level of six lipaemic serum
samples (triglyceride levels in the range 3.9-34"9 mmol/1)
were assayed by the light-scattering and radioimmuno-
assay methods. No significant difference in the results was
noted.
Elevated TBG levels: a total of29 serum samples with TBG
levels greater than 13 mg/1 were assayed for thyroxine by
the light-scattering and radioimmunoassay methods. The
data shown in figure 3 indicate no correlation between
TBG levels and difference in results between the two
methods.
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Figure 3. Difference in thyroxine results obtained by the
light-scattering and radio-immunoassay methods in samples with
high levels of thyroxine-binding globulin.
Paraproteins and autoantibodies: a total of 16 samples known
to contain elevated levels of rheumatoid factor, 35
samples containing paraproteins (concentration range
5-40 g/l), eight samples containing mitochondrial antibo-
dies and six samples containing nuclear factor antibodies
were all assayed for thyroxine by the light-scattering and
radioimmunoassay methods. The data are shown in
figure 4.
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Figure 4. Comparison of thyroxine results obtained with the
light-scattering and radioimmunoassay method with samples
containing paraproteins () (IgG, IgA or IgM) rheumatoid
factor (0) mitochondrial antibodies (U) or nucleur factor
antibodies ). The dotted lines denote the limits of the results
obtained in the main method comparison (see figure 3).
Discussion
Immunoassay methods based on aggregate formation,
particularly those where polyethylene glycols are added
to the reaction mixture, are typically characterized by
short reaction times. Turbidimetric immunoassays have
been described for a variety of proteins and haptens
where reaction times are less than 5 min. This also applies
to assays that employ particle enhancement to improve
the sensitivity of the method. In the method described
calibration can be completed in about 12 min and about
65 patient samples can be analysed in h.
The reagents developed for this light-scattering assay
were found to be robust; it was found that calibrating
once a week showed no gross deterioration in method
precision compared with a daily calibration routine,
although the precision at low thyroxine levels was poorer.
The results obtained with the light-scattering immuno-
assay showed reasonably good agreement with the
radioimmunoassay method. The recovery experiments
and analysis of calibration materials suggested a dis-
crepancy at higher levels of thyroxine. This may simply
reflect the values assigned to the calibration materials.
There appeared to be no consistent interference in the
presence ofincreased levels ofthyroxine binding globulin.
Analysis of samples containing increased antibody titres
did not show the same degree of concordance of results
with radioimmunoassay method although no consistent
interference was observed.
The method described in this report is capable of
adaptation to discrete analysers found in most clinical
laboratories. This offers the possibility ofmore flexibility
in laboratory organization as a result of the employment
of a non-isotopic, rapid automated immunoassay. This
may be of value as clinical biochemists assess the
changing role of the thyroxine assay with the advent of
the more sensitive thyrotropin assays [4].
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